Emzotamig
Based on 1 Customer Validation
Emzotamig is a monoclonal antibody inhibitor targeting tumor necrosis factor (TNF). Emzotamig is promising for research of autoimmune diseases associated with TNF overexpression, such as rheumatoid arthritis and ankylosing spondylitis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 97.35%
- CAS No.: 3037572-57-6
- Masse moléculaire:124.59 kDa
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform TNF Receptor
More
Activité biologique
Description
Isotype
VH-VH-CH1_VL-L-kappa_h-CH2-CH3
Species Reactivity
Human
IC50 & Target
TNFRSF17 & NCR1
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
VH-VH-CH1_VL-L-kappa_h-CH2-CH3
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized BCMA/TNFRSF17 Protein, Human (HEK293, HY-P70827) can bind Emzotamig. The ED50 for this effect is 8.653 ng/mL. -
Immobilized NKp46/NCR1 Protein, Human (HEK293, HY-P77810) can bind Emzotamig. The ED50 for this effect is 172.2 ng/mL.
Chemical Information
-
CAS No. 3037572-57-6
-
Appearance Liquid
-
Masse moléculaire 124.59 kDa
-
Color Colorless to off-white
-
SMILES
N/A
-
Livraison
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
Fiche technique (269 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)